Reimbursement Ready

Billable ICD-10-CM Codes - Page 22

A comprehensive listing of specific diagnosis codes that indicate the highest level of clinical detail for reimbursement purposes.

Non-Hodgkin lymphoma, unspecified, in remission
Status: Billable
C85.9A
Extranodal NK/T-cell lymphoma, nasal type not having achieved remission
Status: Billable
C86.00
Extranodal NK/T-cell lymphoma, nasal type, in remission
Status: Billable
C86.01
Hepatosplenic T-cell lymphoma not having achieved remission
Status: Billable
C86.10
Hepatosplenic T-cell lymphoma, in remission
Status: Billable
C86.11
Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission
Status: Billable
C86.20
Enteropathy-type (intestinal) T-cell lymphoma, in remission
Status: Billable
C86.21
Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission
Status: Billable
C86.30
Subcutaneous panniculitis-like T-cell lymphoma, in remission
Status: Billable
C86.31
Blastic NK-cell lymphoma not having achieved remission
Status: Billable
C86.40
Blastic NK-cell lymphoma, in remission
Status: Billable
C86.41
Angioimmunoblastic T-cell lymphoma not having achieved remission
Status: Billable
C86.50
Angioimmunoblastic T-cell lymphoma, in remission
Status: Billable
C86.51
Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
Status: Billable
C86.60
Primary cutaneous CD30-positive T-cell proliferations, in remission
Status: Billable
C86.61
Waldenström macroglobulinemia not having achieved remission
Status: Billable
C88.00
Waldenström macroglobulinemia, in remission
Status: Billable
C88.01
Heavy chain disease not having achieved remission
Status: Billable
C88.20
Heavy chain disease, in remission
Status: Billable
C88.21
Immunoproliferative small intestinal disease not having achieved remission
Status: Billable
C88.30
Immunoproliferative small intestinal disease, in remission
Status: Billable
C88.31
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
Status: Billable
C88.40
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission
Status: Billable
C88.41
Other malignant immunoproliferative diseases not having achieved remission
Status: Billable
C88.80
Other malignant immunoproliferative diseases, in remission
Status: Billable
C88.81
Malignant immunoproliferative disease, unspecified not having achieved remission
Status: Billable
C88.90
Malignant immunoproliferative disease, unspecified, in remission
Status: Billable
C88.91
Multiple myeloma not having achieved remission
Status: Billable
C90.00
Multiple myeloma in remission
Status: Billable
C90.01
Multiple myeloma in relapse
Status: Billable
C90.02
Plasma cell leukemia not having achieved remission
Status: Billable
C90.10
Plasma cell leukemia in remission
Status: Billable
C90.11
Plasma cell leukemia in relapse
Status: Billable
C90.12
Extramedullary plasmacytoma not having achieved remission
Status: Billable
C90.20
Extramedullary plasmacytoma in remission
Status: Billable
C90.21
Extramedullary plasmacytoma in relapse
Status: Billable
C90.22
Solitary plasmacytoma not having achieved remission
Status: Billable
C90.30
Solitary plasmacytoma in remission
Status: Billable
C90.31
Solitary plasmacytoma in relapse
Status: Billable
C90.32
Acute lymphoblastic leukemia not having achieved remission
Status: Billable
C91.00
Acute lymphoblastic leukemia, in remission
Status: Billable
C91.01
Acute lymphoblastic leukemia, in relapse
Status: Billable
C91.02
Chronic lymphocytic leukemia of B-cell type not having achieved remission
Status: Billable
C91.10
Chronic lymphocytic leukemia of B-cell type in remission
Status: Billable
C91.11
Chronic lymphocytic leukemia of B-cell type in relapse
Status: Billable
C91.12
Prolymphocytic leukemia of B-cell type not having achieved remission
Status: Billable
C91.30
Prolymphocytic leukemia of B-cell type, in remission
Status: Billable
C91.31
Prolymphocytic leukemia of B-cell type, in relapse
Status: Billable
C91.32
Hairy cell leukemia not having achieved remission
Status: Billable
C91.40
Hairy cell leukemia, in remission
Status: Billable
C91.41
Hairy cell leukemia, in relapse
Status: Billable
C91.42
Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission
Status: Billable
C91.50
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission
Status: Billable
C91.51
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse
Status: Billable
C91.52
Prolymphocytic leukemia of T-cell type not having achieved remission
Status: Billable
C91.60
Prolymphocytic leukemia of T-cell type, in remission
Status: Billable
C91.61
Prolymphocytic leukemia of T-cell type, in relapse
Status: Billable
C91.62
Lymphoid leukemia, unspecified not having achieved remission
Status: Billable
C91.90
Lymphoid leukemia, unspecified, in remission
Status: Billable
C91.91
Lymphoid leukemia, unspecified, in relapse
Status: Billable
C91.92
Mature B-cell leukemia Burkitt-type not having achieved remission
Status: Billable
C91.A0
Mature B-cell leukemia Burkitt-type, in remission
Status: Billable
C91.A1
Mature B-cell leukemia Burkitt-type, in relapse
Status: Billable
C91.A2
Other lymphoid leukemia not having achieved remission
Status: Billable
C91.Z0
Other lymphoid leukemia, in remission
Status: Billable
C91.Z1
Other lymphoid leukemia, in relapse
Status: Billable
C91.Z2
Acute myeloblastic leukemia, not having achieved remission
Status: Billable
C92.00
Acute myeloblastic leukemia, in remission
Status: Billable
C92.01
Acute myeloblastic leukemia, in relapse
Status: Billable
C92.02
Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
Status: Billable
C92.10
Chronic myeloid leukemia, BCR/ABL-positive, in remission
Status: Billable
C92.11
Chronic myeloid leukemia, BCR/ABL-positive, in relapse
Status: Billable
C92.12
Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
Status: Billable
C92.20
Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
Status: Billable
C92.21
Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
Status: Billable
C92.22
Myeloid sarcoma, not having achieved remission
Status: Billable
C92.30
Myeloid sarcoma, in remission
Status: Billable
C92.31
Myeloid sarcoma, in relapse
Status: Billable
C92.32
Acute promyelocytic leukemia, not having achieved remission
Status: Billable
C92.40
Acute promyelocytic leukemia, in remission
Status: Billable
C92.41
Acute promyelocytic leukemia, in relapse
Status: Billable
C92.42
Acute myelomonocytic leukemia, not having achieved remission
Status: Billable
C92.50
Acute myelomonocytic leukemia, in remission
Status: Billable
C92.51
Acute myelomonocytic leukemia, in relapse
Status: Billable
C92.52
Acute myeloid leukemia with 11q23-abnormality not having achieved remission
Status: Billable
C92.60
Acute myeloid leukemia with 11q23-abnormality in remission
Status: Billable
C92.61
Acute myeloid leukemia with 11q23-abnormality in relapse
Status: Billable
C92.62
Myeloid leukemia, unspecified, not having achieved remission
Status: Billable
C92.90
Myeloid leukemia, unspecified in remission
Status: Billable
C92.91
Myeloid leukemia, unspecified in relapse
Status: Billable
C92.92
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
Status: Billable
C92.A0
Acute myeloid leukemia with multilineage dysplasia, in remission
Status: Billable
C92.A1
Acute myeloid leukemia with multilineage dysplasia, in relapse
Status: Billable
C92.A2
Other myeloid leukemia not having achieved remission
Status: Billable
C92.Z0
Other myeloid leukemia, in remission
Status: Billable
C92.Z1
Other myeloid leukemia, in relapse
Status: Billable
C92.Z2
Acute monoblastic/monocytic leukemia, not having achieved remission
Status: Billable
C93.00
Acute monoblastic/monocytic leukemia, in remission
Status: Billable
C93.01
Acute monoblastic/monocytic leukemia, in relapse
Status: Billable
C93.02
Chronic myelomonocytic leukemia not having achieved remission
Status: Billable
C93.10